caffeic acid phenethyl ester has been researched along with monorden in 3 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (monorden) | Trials (monorden) | Recent Studies (post-2010) (monorden) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 341 | 0 | 99 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | monorden (IC50) |
|---|---|---|---|
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1 | Homo sapiens (human) | 400 | |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | Homo sapiens (human) | 400 | |
| ATP-dependent molecular chaperone HSP82 | Saccharomyces cerevisiae S288C | 0.1193 | |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | 0.2092 | |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | 0.1148 | |
| ATP-dependent molecular chaperone HSC82 | Saccharomyces cerevisiae S288C | 0.2 | |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | 3.27 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.027 | |
| Proto-oncogene tyrosine-protein kinase Src | Rattus norvegicus (Norway rat) | 0.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and monorden
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |